首页|杞菊地黄丸联合天麻钩藤饮治疗高血压的Meta分析

杞菊地黄丸联合天麻钩藤饮治疗高血压的Meta分析

扫码查看
目的 系统评价杞菊地黄丸联合天麻钩藤饮治疗高血压的疗效和安全性.方法 检索相关数据库中公开发表的关于杞菊地黄丸联合天麻钩藤饮治疗高血压的随机对照试验,提取数据并进行Meta分析.结果 共纳入31篇文献,实验组1931例、对照组1 852例高血压患者.Meta分析结果显示,杞菊地黄丸联合天麻钩藤饮治疗高血压的降压效果[SBP:MD=12.11,95%CI(10.11,14.10);DBP:MD=8.48,95%CI(6.91,10.06)]和有效率[RR=1.18,95%CI(1.15,1.21)]均显著优于常规西药治疗,且不良反应发生率显著低于常规西药治疗[RR=0.41,95%CI(0.31,0.53)].相比单独使用杞菊地黄丸联合天麻钩藤饮,与常规西药联合并未显著增强降压和治疗效果,反而导致不良反应率增加1.93倍.结论 杞菊地黄丸联合天麻钩藤饮治疗高血压的疗效和安全性优于常规西药治疗,与常规西药联合使用时需注意不良反应的风险.
Meta-analysis of Qiju Dihuang Pills Combined with Tianma Gouteng Yin for Treating Hypertension
Objective To systematically evaluate the efficacy and safety of Qiju Dihuang pills combined with Tianma Gouteng yin in treating hypertension.Methods Performing a systematic database search for published randomized controlled trials investigating the efficacy of Qiju Dihuang pills combined with Tianma Gouteng yin in treating hypertension,extracting data,and conducting a meta-analysis.Results A total of 31 studies involving 3 783 hypertensive patients were included.Meta-analysis results revealed that the combined therapy of Qiju Dihuang pills and Tianma Gouteng yin significantly surpassed conventional western medicine in terms of reducing blood pressure[SBP:MD=12.11,95%CI(10.11,14.10);DBP:MD=8.48,95%CI(6.91,10.06)]and efficacy rate[RR=1.18,95%CI(1.15,1.21)],with a notably lower incidence of adverse reactions compared to conventional western medicine[RR=0.41,95%CI(0.31,0.53)].Compared to the combined use of Qiju Dihuang pills with Tianma Gouteng yin alone,the combination with conventional western medicine did not significantly enhance the antihypertensive and therapeutic effects.Instead,it resulted in a 1.93-fold increase in the incidence of adverse reactions.Conclusion The efficacy and safety of Qiju Dihuang pills combined with Tianma Gouteng yin in treating hypertension are superior to conventional western medicine treatment.However,when used in combination with conventional western medicine,attention should be paid to the risk of adverse reactions.

HypertensionQiju Dihuang pillTianma Gouteng yinMeta-analysis

解海宁、沈冲、姚应水

展开 >

皖南医学院公共卫生学院/慢性病防制研究所,安徽芜湖 241002

南京医科大学公共卫生学院,江苏南京 211116

高血压 杞菊地黄丸 天麻钩藤饮 Meta分析

国家自然科学基金安徽省"特支计划"创新领军人才项目

81874280T000516

2024

现代中药研究与实践
安徽中医药高等专科学校,

现代中药研究与实践

CSTPCD
影响因子:0.409
ISSN:1673-6427
年,卷(期):2024.38(2)